Lloyd Tran
Lloyd Tran publishes mostly in Physiology, Pharmacology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases and Diet and metabolism studies.
- World rank
- #6,977,385 of 7,710,434 ranked researchers
- Rank in United States
- #1,572,718 of 1,627,098
- Works
- 21
- Citations
- 3
- Citations per work
- 0.1
What does Lloyd Tran research?
Lloyd Tran's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (14%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1048.9%
- Medicine1048.9%
- Everything else630.1%
- Life Sciences421.0%
- 1Physiology21% of their works
- 2Pharmacology14% of their works
- 3Molecular Biology14% of their works
- 4Psychiatry and Mental health7% of their works
- 5Neurology7% of their works
- 6Pulmonary and Respiratory Medicine7% of their works
Research topics
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Diet and metabolism studies
- Dementia and Cognitive Impairment Research
- Cancer-related cognitive impairment studies
- Metabolism, Diabetes, and Cancer
- Phosphodiesterase function and regulation
- Neurological Disorders and Treatments
Which keywords describe Lloyd Tran's research?
The keywords of their largest research topics: Alzheimer's Disease, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Acetylcholinesterase, Cholinesterase Inhibitors, Chemotherapy and Cognitive Function.
- cAMP Signaling
- Cyclic Nucleotide Phosphodiesterases
- Cerebrolysin
- Mild Cognitive Impairment
- Ketogenic Diet
- Cognitive Function
- Cholinesterase Inhibitors
- Tau Pathology
- Oxidative Stress
- Alzheimer's Disease
- Amyloid Hypothesis
- Acetylcholinesterase
- Chemotherapy
- Dementia
- Low-Carbohydrate Diet
- AMP-Activated Protein Kinase
- Citicoline
- Metformin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Alzheimer's Disease134 topics
- Oxidative Stress82 topics
- Amyloid Hypothesis61 topic
- Tau Pathology61 topic
- Acetylcholinesterase51 topic
- Cholinesterase Inhibitors51 topic
- Chemotherapy31 topic
- Cognitive Function31 topic
- Dementia31 topic
- Ketogenic Diet31 topic
- Low-Carbohydrate Diet31 topic
- Mild Cognitive Impairment31 topic
- AMP-Activated Protein Kinase21 topic
- Cerebrolysin21 topic
- Citicoline21 topic
- Cyclic Nucleotide Phosphodiesterases21 topic
- Metformin21 topic
- cAMP Signaling21 topic
Where does Lloyd Tran work?
Lloyd Tran's main affiliation in the publication record is Biomed Research Institute, United States.
How many publications and citations does Lloyd Tran have?
OpenAlex counts 21 works and 3 citations for Lloyd Tran, an h-index of 1, ranking #6,977,385 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lloyd Tran. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.